Abstract | AIM: METHODS: A retrospective case series was conducted on extremely low birth infants, <1000 g birthweight, who survived hospitalisation, had no major congenital anomalies and had all their care in our institution RESULTS: During this 6-year period, 231 ELBW infants survived hospitalisation at our institution. Of the 231 patients, parathyroid hormone (PTH) levels were performed in 66 of these patients (29%) and were elevated in 54 patients (82% of those tested). The timing of this testing was sporadic and was often performed after recognising osteopenia on radiography. Of the 54 patients with high PTH levels, 44 (81%) were treated with CaCO(3) and PTH levels were monitored while on therapy. The average duration of therapy was 41 ± 28 days, with 64% of PTH levels returning to normal before discharge. CONCLUSIONS:
|
Authors | Alvaro Moreira, Melissa February, Cara Geary |
Journal | Journal of paediatrics and child health
(J Paediatr Child Health)
Vol. 49
Issue 1
Pg. E12-6
(Jan 2013)
ISSN: 1440-1754 [Electronic] Australia |
PMID | 23293851
(Publication Type: Evaluation Study, Journal Article)
|
Copyright | © 2013 The Authors. Journal of Paediatrics and Child Health © 2013 Paediatrics and Child Health Division (Royal Australasian College of Physicians). |
Chemical References |
- Biomarkers
- Parathyroid Hormone
- Calcium Carbonate
|
Topics |
- Biomarkers
(blood)
- Bone Diseases, Metabolic
(diagnostic imaging, etiology)
- Calcium Carbonate
(therapeutic use)
- Dietary Supplements
- Female
- Humans
- Hyperparathyroidism, Secondary
(blood, diagnosis, drug therapy, epidemiology)
- Incidence
- Infant, Extremely Low Birth Weight
- Infant, Newborn
- Infant, Premature
- Infant, Premature, Diseases
(blood, diagnosis, drug therapy, etiology)
- Male
- Parathyroid Hormone
(blood)
- Radiography
- Retrospective Studies
- Treatment Outcome
|